Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Olivia Madan

Plastic Surgery Nashville, TN Medical Doctor

NPI 1861805921 CMS profile 8800289

1914 Charlotte Ave Ste 101, Nashville, TN 37203

Open in the dashboard

General payments

$4,517

120 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Olivia Madan of Nashville, TN is reported in the CMS Open Payments database as having received $4,517 across 120 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $592 22
2024 General $778 20
2023 General $558 17
2022 General $1,022 29
2021 General $1,041 24
2020 General $527 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Olivia Madan
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Olivia Madan were reported at $592. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Olivia Madan Plastic Surgery median Middle half National median
2019 $0 $371 $122–$1,483 $163
2020 $527 $158 $52–$438 $114
2021 $1,041 $249 $87–$752 $132
2022 $1,022 $274 $102–$793 $149
2023 $558 $299 $113–$891 $160
2024 $778 $361 $124–$1,062 $164
2025 $592 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. AbbVie, Inc. $1,144 41 payments
  2. Allergan Inc. $1,080 30 payments
  3. Sientra, Inc. $614 13 payments
  4. TELA Bio, Inc. $404 11 payments
  5. Integra LifeSciences Corporation $354 2 payments
  6. Revance Therapeutics, Inc. $287 9 payments
  7. Galderma Laboratories, L.P. $252 7 payments
  8. Aziyo Biologics, Inc. $165 1 payment
  9. Bard Peripheral Vascular, Inc. $135 2 payments
  10. Mentor Worldwide LLC $49 2 payments
  11. Other $32 2 payments

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Food and Beverage $3,948 110 payments
  2. Long term medical supply or device loan $326 1 payment
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $243 9 payments
Products named General payments · program years 2020–2025
  1. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $720 23 payments
  2. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $614 13 payments
  3. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $502 18 payments
  4. OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) $404 11 payments
  5. BOTOX $353 15 payments
  6. DuraSorb Monofilament Mesh $326 1 payment
  7. DAXXIFY $287 9 payments
  8. ECM Patch,Pouch $165 1 payment
  9. NATRELLE $165 2 payments
  10. GalaFLEX $135 2 payments
  11. Other $222 9 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

120 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record